Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-1041

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs ; day:16 ; month:1 ; year:2021 ; pages:1-9
European journal of clinical pharmacology ; (16.1.2021), 1-9

Creator: Courlet, Perrine
Guidi, Monia
Alves Saldanha, Susana
Cavassini, Matthias
Stoeckle, Marcel
Buclin, Thierry
Marzolini, Catia
Decosterd, Laurent A.
Csajka, Chantal

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00228-020-03060-2

URN: urn:nbn:de:101:1-2021030817490741683418

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Courlet, Perrine
Guidi, Monia
Alves Saldanha, Susana
Cavassini, Matthias
Stoeckle, Marcel
Buclin, Thierry
Marzolini, Catia
Decosterd, Laurent A.
Csajka, Chantal
SpringerLink (Online service)

Other Objects (12)

Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin

Deep learning-enabled natural language processing to identify directional pharmacokinetic drug–drug interactions

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

The influence of pharmacogenetics on the clinical relevance of pharmacokinetic drug–drug interactions: drug–gene, drug–gene–gene and drug–drug–gene interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin

Deep learning-enabled natural language processing to identify directional pharmacokinetic drug–drug interactions

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

The influence of pharmacogenetics on the clinical relevance of pharmacokinetic drug–drug interactions: drug–gene, drug–gene–gene and drug–drug–gene interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin

Deep learning-enabled natural language processing to identify directional pharmacokinetic drug–drug interactions

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

The influence of pharmacogenetics on the clinical relevance of pharmacokinetic drug–drug interactions: drug–gene, drug–gene–gene and drug–drug–gene interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin

Deep learning-enabled natural language processing to identify directional pharmacokinetic drug–drug interactions

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

The influence of pharmacogenetics on the clinical relevance of pharmacokinetic drug–drug interactions: drug–gene, drug–gene–gene and drug–drug–gene interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin

Deep learning-enabled natural language processing to identify directional pharmacokinetic drug–drug interactions

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

The influence of pharmacogenetics on the clinical relevance of pharmacokinetic drug–drug interactions: drug–gene, drug–gene–gene and drug–drug–gene interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Physiologically based pharmacokinetic model to predict drug–drug interactions with the antibody–drug conjugate enfortumab vedotin

Deep learning-enabled natural language processing to identify directional pharmacokinetic drug–drug interactions

Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions

The influence of pharmacogenetics on the clinical relevance of pharmacokinetic drug–drug interactions: drug–gene, drug–gene–gene and drug–drug–gene interactions

A Review of Daclatasvir Drug–Drug Interactions

Drug–Drug Interactions with Direct Oral Anticoagulants

Extracting drug-drug interactions from biomedical texts

Physiologically based pharmacokinetic modeling to assess metabolic drug–drug interaction risks and inform the drug label for fedratinib

Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

Investigating the complexity of time-dependent drug-drug and drug-food interactions involving CYP3A4 using physiologically based pharmacokinetic modeling

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions

Case report: Medical cannabis—warfarin drug-drug interaction

Related objects

Reset password